Astrana Health, Inc. Form 8-K Summary
Business Context and Reporting Period
Astrana Health, Inc. (ASTH), a Delaware corporation, filed this Current Report on Form 8-K on August 7, 2024. The filing serves to announce the Company's financial results for the three and six months ended June 30, 2024. The Company's principal executive offices are located in Alhambra, California.
Key Financial Metrics
The filing text itself does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release and supplemental data furnished as Exhibits 99.1 and 99.2, which are incorporated by reference but not detailed in the body of this 8-K.
Material Changes
No specific material changes versus prior periods are quantified in the text of this filing. The report indicates that the Company has issued a press release detailing these results, but the specific variances are not listed in the 8-K summary text.
Guidance, Outlook, and Risks
The filing does not contain specific management commentary, forward-looking guidance, risk factors, or unusual items within its text. It explicitly states that the information furnished pursuant to Item 2.02, including the exhibits, shall not be deemed "filed" for purposes of Section 18 of the Exchange Act nor incorporated by reference in other filings, except as expressly set forth by specific reference.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net loss, and cash position figures for the three and six months ended June 30, 2024.
- Examine Exhibit 99.2 (Supplemental Data) for detailed operational metrics and segment performance.
- Verify the Company's liquidity status and cash runway as detailed in the referenced exhibits.
- Check for any updated guidance or strategic shifts mentioned in the press release that are not captured in this 8-K summary.